logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
14/08/2025
Merck's Keytruda has received approval from the Canadian Department of Health for the treatment of head and neck squamous cell carcinoma (HNSCC) with PD-L1 expression.
Latest
1 m ago
The Shanghai Composite Index broke through the 3700 point mark in the morning session, hitting a new high in nearly four years, with a 0.49% increase.
2 m ago
The FTSE China A50 index futures increased by 1%.
2 m ago
The CEO of Lenovo said that over 40% of artificial intelligence PC users in China are active users.
2 m ago
Lenovo CEO: The current impact of tariffs on business is limited. The implications of Trump's proposed 100% tariff on chips are still unclear, but the company will not be at a disadvantage. Confidence in the outlook for the 2026 fiscal year has increased compared to the previous quarter. Despite geopolitical uncertainties, shipments of AI PCs remain on track.
2 m ago
Fujian terminates typhoon and flood emergency response, Xiamen's sea passenger transport routes gradually resume operations.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.